Ingrediome

Ingrediome is a biotech company in Tel Aviv-Yafo, Israel, founded in 2022. It has 2 recorded funding rounds, most recently a Seed in February 2024.

Delicious & Affordable Meat powered by Precision Fermentation

Headquarters
Tel Aviv-Yafo
Employees
11–50
Founded
2022
Business Model
B2B
Last Round
SeedFeb 2024
Rounds
2

Indexed holds 2 funding rounds and 7 investors for this company. The full record is or through the API.

About

Ingrediome is an Israeli biotech startup producing nature-identical animal muscle proteins using photosynthetic precision fermentation. Founded in 2022 by Aviel Even and Michael Kaholi, the company aims to solve taste and texture challenges in alternative proteins by developing recombinant animal matrix proteins for the food industry.

Summary

It lists 11–50 employees. Its most recent funding was a Seed round in Feb 2024. Investors include SOSV, IndieBio and Alumni Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
SeedSeed RoundFeb 2024

Sign up to see all 2 events

Funding: Seed. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ingrediome on Indexed.vc
<a href="https://indexed.vc/companies/ingrediome"><img src="https://indexed.vc/api/badge/company/ingrediome" alt="Ingrediome on Indexed.vc" width="260" height="76" /></a>